Thyroid hormone receptor beta (THRβ) Agonists in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Bridging the Gap Between Promise and Practice

Authors

  • Mohamed Mahmoud Marey Faculty of Medicine, Alexandria University, Alexandria, Egypt; Medical Research Group of Egypt, Negida Academy, Arlington, MA, USA https://orcid.org/0009-0002-1572-0740
  • Farah Alkilani Jackson Health System internal medicine residency program, University of Miami, Miami, FL, USA https://orcid.org/0000-0003-3571-1614
  • Amany Mahmoud Genidy Medical Research Group of Egypt, Negida Academy, Arlington, MA, USAFaculty of Medicine, Tanta University, Tanta, Egypt; Faculty of Medicine, Tanta University, Tanta, Egypt
  • Jawad Mahmood Acute and General Medicine, St Richard’s Hospital, University Hospitals Sussex, NHS Foundation Trust, United Kingdom https://orcid.org/0009-0009-3346-8017
  • Manar Adel Faculty of Clinical Pharmacy, Tanta University, Gharbia, Egypt
  • Mahmoud M. Elhady Faculty of Medicine, Benha University, Qalubiya, Egypt

DOI:

https://doi.org/10.15403/jgld-6328

Keywords:

metabolic dysfunction-associated steatohepatitis, MASH-cirrhosis, thyroid hormone receptor-β agonist,, Resmetirom, non-alcoholic fatty liver disease, MASH, NASH, THRβ

Downloads

Published

2025-12-26

How to Cite

1.
Mahmoud Marey M, Alkilani F, Mahmoud Genidy A, Mahmood J, Adel M, M. Elhady M. Thyroid hormone receptor beta (THRβ) Agonists in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Bridging the Gap Between Promise and Practice. JGLD [Internet]. 2025 Dec. 26 [cited 2026 Feb. 2];34(4). Available from: https://www.jgld.ro/jgld/index.php/jgld/article/view/6328

Issue

Vol. 34 No. 4: December 2025

Section

Editorial

License

Copyright (c) 2025 Journal of Gastrointestinal and Liver Diseases

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.